Boehringer Ingelheim: all 2,305 studies
Page 6 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Nintedanib and Weekly Docetaxel in Lung AdenocarcinomaCompletedNCT02668393Phase 1Results posted
- Influence of Bosentan on the Pharmacokinetics of NintedanibCompletedNCT02667704Phase 1Results posted
- Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus PlaceboCompletedNCT02657408Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male VolunteersCompletedNCT02652416Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPDCompletedNCT02642614Phase 1Results posted
- Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedNCT02640612Phase 3Results posted
- Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedNCT02636907Phase 2Results posted
- Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female SubjectsCompletedNCT02635750Phase 1Results posted
- Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN StudyCompletedNCT02632747Phase 2Results posted
- A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)CompletedNCT02632721Phase 1/2Results posted
- Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in JapanCompletedNCT02631057Results posted
- Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedNCT02629965Phase 3Results posted
- To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another TabletCompletedNCT02629354Phase 1Results posted
- To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCLCompletedNCT02624492Phase 2Results posted
- All-Case Surveillance of Ofev in Patients With IPF in JapanCompletedNCT02607722Results posted
- Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or AutoinjectorCompletedNCT02606903Phase 1Results posted
- A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in CombinationCompletedNCT02606877Phase 4Results posted
- Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male VolunteersCompletedNCT02597998Phase 1Results posted
- Afatinib in NSCLC With HER2 MutationCompletedNCT02597946Phase 2Results posted
- A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung FibrosisCompletedNCT02597933Phase 3Results posted
- Patient Convenience StudyCompletedNCT02597920Results posted
- RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous ThromboembolismCompletedNCT02596230Results posted
- Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02589639Phase 4Results posted
- Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RACompletedNCT02589626Phase 4Results posted
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)CompletedNCT02580591Phase 3Results posted
- Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPFCompletedNCT02579603Phase 4Results posted
- Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed ConditionsCompletedNCT02577315Phase 1Results posted
- DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)CompletedNCT02574845Phase 1Results posted
- Actual Use Study of Tamsulosin in MenCompletedNCT02573311Phase 3Results posted
- Relative Bioavailability of 2 Oral Formulations of NintedanibCompletedNCT02572752Phase 1Results posted
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol HydrochlorideCompletedNCT02572609Phase 1Results posted
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male VolunteersCompletedNCT02525679Phase 1Results posted
- BI 894999 First in Human Dose Finding Study in Advanced MalignanciesCompletedNCT02516553Phase 1Results posted
- Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.CompletedNCT02516098Phase 1Results posted
- Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma PatientsCompletedNCT02514239Phase 1Results posted
- Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or OlderCompletedNCT02514174Phase 4Results posted
- Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male SubjectsCompletedNCT02513446Phase 1Results posted
- Specific Use-result Surveillance of Spiriva Respimat in AsthmaticsCompletedNCT02489981Results posted
- Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489968Phase 3Results posted
- Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489942Results posted
- Evaluation of the Impact of Nurse-led Telephone on Treatment ComplianceTerminatedNCT02483416Results posted
- Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes MellitusCompletedNCT02453555Phase 3Results posted
- Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care SettingsCompletedNCT02440854Results posted
- BI 409306 Cardiac Safety Trial in Healthy VolunteersCompletedNCT02438683Phase 1Results posted
- Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial FibrillationCompletedNCT02433366Results posted
- Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.CompletedNCT02417844Phase 1Results posted
- Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.CompletedNCT02417831Phase 1Results posted
- BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular LymphomaTerminatedNCT02417129Phase 3Results posted
- Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)CompletedNCT02414958Phase 3Results posted
- Asthma Biomarker StudyCompletedNCT02392481Results posted
- Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy VolunteersCompletedNCT02392468Phase 1Results posted
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male SubjectsCompletedNCT02383888Phase 1Results posted
- Trial of Afatinib in Pediatric TumoursCompletedNCT02372006Phase 1/2Results posted
- Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes MellitusCompletedNCT02367131Results posted
- Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809CompletedNCT02362516Phase 1Results posted
- Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)CompletedNCT02348723Phase 4Results posted
- Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male SubjectsCompletedNCT02342717Phase 1Results posted
- BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02337907Phase 2Results posted
- Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)CompletedNCT02337283Phase 1Results posted
- Safety and Pharmacokinetics of Multiple Doses of BI 655064 in Healthy Chinese Male VolunteersCompletedNCT02331277Phase 1Results posted
- Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back PainCompletedNCT02300311Phase 3Results posted
- Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line ChemotherapyCompletedNCT02300298Phase 1Results posted
- Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedNCT02296138Phase 3Results posted
- GIOTRIF rPMS in Korean Patients With NSCLCCompletedNCT02285361Results posted
- A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.CompletedNCT02281773Phase 2Results posted
- BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid TumoursCompletedNCT02273388Phase 1Results posted
- Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung CancerCompletedNCT02272413Phase 3Results posted
- Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and FemaleCompletedNCT02266472Phase 1Results posted
- Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor MetabolizersCompletedNCT02248259Phase 1Results posted
- Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or DiscomfortCompletedNCT02242305Phase 3Results posted
- Phase I/II Trial to Investigate BI 836858 in Myelodysplastic SyndromesTerminatedNCT02240706Phase 2Results posted
- Alzheimer Disease Proof of Concept Study With BI 409306 Versus PlaceboCompletedNCT02240693Phase 2Results posted
- Linagliptin as Add on to Basal Insulin in the ElderlyCompletedNCT02240680Phase 4Results posted
- Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)CompletedNCT02240667Results posted
- Evaluation of Potential Off-label Use of Dabigatran Etexilate in EuropeCompletedNCT02240654Results posted
- Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)CompletedNCT02239120Phase 3Results posted
- Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)CompletedNCT02231918Phase 2Results posted
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02231177Phase 1Results posted
- LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational ResearchTerminatedNCT02231164Phase 3Results posted
- Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy SubjectsCompletedNCT02230995Phase 1Results posted
- Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe DepressionCompletedNCT02229825Phase 4Results posted
- Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of AgeCompletedNCT02223260Phase 2Results posted
- Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy VolunteersCompletedNCT02222168Phase 1Results posted
- Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT02208843Phase 4Results posted
- BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)CompletedNCT02204072Phase 1Results posted
- Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaCompletedNCT02201329Phase 1Results posted
- Safety of Dabigatran Etexilate in Blood Clot Prevention in ChildrenCompletedNCT02197416Phase 3Results posted
- Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of LinagliptinCompletedNCT02197078Results posted
- Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)CompletedNCT02191891Phase 1Results posted
- Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy VolunteersCompletedNCT02191865Phase 1Results posted
- Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male VolunteersCompletedNCT02183675Phase 1Results posted
- 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and HypertensionCompletedNCT02182830Phase 3Results posted
- Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected PatientsCompletedNCT02176525Phase 1Results posted
- Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyCompletedNCT02173769Results posted
- Bioavailability of Different Applications of Dabigatran in Healthy VolunteersCompletedNCT02171611Phase 1Results posted
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)CompletedNCT02164864Phase 3Results posted
- Management of Major Bleeding Events in Atrial Fibrillation Patients Using PradaxaCompletedNCT02149303Results posted
- Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)CompletedNCT02149108Phase 3Results posted
- Multiple Rising Oral Doses of BI 691751 in Healthy Male SubjectsTerminatedNCT02148107Phase 1Results posted
- Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid TumoursCompletedNCT02145741Phase 1Results posted